Allergan to Stop Selling Some Breast Implants After Cancer Tie

Bookmark
(Bloomberg) -- Allergan Plc will stop selling some breast implants after the U.S. Food and Drug Administration said that textured implants had been associated with a rare type of blood cancer.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.